Belite Bio annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Belite Bio Depreciation & Amortization Growth & History (BLTE)
Belite Bio's depreciation and amortization was $184,000 for fiscal 2025.
View full Belite Bio company overviewBelite Bio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $184,000 | $16,000 | +9.52% |
| 2024 | 2024-12-31 | $168,000 | $29,000 | +20.86% |
| 2023 | 2023-12-31 | $139,000 | $75,000 | +117.19% |
| 2022 | 2022-12-31 | $64,000 | $34,000 | +113.33% |
| 2021 | 2021-12-31 | $30,000 | $13,000 | +76.47% |
| 2020 | 2020-12-31 | $17,000 | — | — |
Belite Bio quarterly depreciation and amortization
Q4.24
Q4.25
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $117,000 | −$1,000 | −0.85% |
| Q4 2024 | 2024-12-31 | $118,000 | — | — |
Belite Bio depreciation and amortization trends
Over the last five fiscal years, Belite Bio's depreciation and amortization increased from $17,000 to $184,000, a change of $167,000. The latest reported quarter, Q4 2025, shows $117,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Belite Bio source filings ↗